PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: Prescient Gains IP Rights in CAR-T Collaboration, page-27

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    Thanks psych.

    So, they haven't put significant money in for a year and a bit. That's just one observation in the mix.

    I like the look of the pedigree and data so far for PTX-100 and PTX-200. But the ambiguous and seemingly copy and paste CEO updates (that have confused the market about trials post late 2019 results) are very underwhelming.

    Hopefully the data continues to prove successful in the long run. IMHO money to made in PTX in the meantime.

    GLTA patients and holders.

    Last edited by DTshares: 13/05/20
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.